WORLD ANTI-MICROBIAL RESISTANCE CONGRESS

 

INNOVATION. COLLABORATION. COMMERCIALISATION.

FOR PHARMA & BIOTECH, PAYERS, REGULATORS AND THEIR PARTNERS

26 - 27 March 2019, Steigenberger, Berlin

 

 

WHAT IS THE WORLD ANTI-MICROBIAL RESISTANCE CONGRESS?

Networking


It’s not just about the conference sessions, our Congress recognises the importance of networking.

With roundtable discussions, themed networking receptions, networking lunches and our networking app we offer plenty of opportunities to network with your peers and continue conversations in good company.
 

 

FIND OUT MORE

Conference


The World Anti-Microbial Resisitance Congress brings together all the stakeholders involved in developing new antimicrobial drugs and diagnostics.

The event focusses on one of the most important challenges currently facing the global healthcare sector: tackling scientific and economic issues around antimicrobial resistance.

 

FIND OUT MORE

Exhibition

Exhibit


This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.

Sponsorship packages are tailored to meet your specific marketing goals. So don’t delay, contact us now to se how we can help your business.

 

FIND OUT MORE

SPEAKERS FROM THE SERIES

Recent speakers at our 2017 Washington Congress

 

  • Rosemarie Aurigemma at World Anti-Microbial Congress US 2016
    Rosemarie Aurigemma
    Chief Biodefense Drug Development Section
    NIAID, NIH
    Mr Stefano Bertuzzi at World Anti-Microbial Congress US 2016
    Mr Stefano Bertuzzi
    Executive Director/CEO
    American Society for Microbiology
  • James Del Rosso at World Anti-Microbial Congress US 2016
    James Del Rosso
    DO, FAOCD, FAAD, ADJ Clinical Professor, (Dermatology)
    Touro University Nevada
    Michael Draper at World Anti-Microbial Congress US 2016
    Michael Draper
    Senior Director, External Science and Partnering
    Sanofi
  • Michael Dudley at World Anti-Microbial Congress US 2016
    Michael Dudley
    Senior VP of Research and Development and CSO
    The Medicines Company
    Barry Eisenstein at World Anti-Microbial Congress US 2016
    Barry Eisenstein
    Distinguished Physician, Antimicrobials
    Merck & Co.
  • Robert Eisinger at World Anti-Microbial Congress US 2016
    Robert Eisinger
    Senior Health Science Policy Advisor, Division of Program Coordination, Planning, and Strategic Initiatives,
    NIH
    Marcos Espinal at World Anti-Microbial Congress US 2016
    Marcos Espinal
    Director, Dept of Communicable Diseases and Health Analysis
    PAHO/WHO
  • Scott Evans at World Anti-Microbial Congress US 2016
    Scott Evans
    Director, Statistical and Data Management Center (SDMC) for the Antibacterial Resistance Leadership Group (ARLG)
    Harvard University
    Tamar Ghosh at World Anti-Microbial Congress US 2016
    Tamar Ghosh
    Lead, Longitude Prize
    Nesta
  • Steven Gilman at World Anti-Microbial Congress US 2016
    Steven Gilman
    Chairman & CEO
    Contrafect Corporation
    Judy Hackett at World Anti-Microbial Congress US 2016
    Judy Hackett
    Project Coordinator, Drive-AB, Global Payer Evidence Director
    AstraZeneca
  • Chris Houchens at World Anti-Microbial Congress US 2016
    Chris Houchens
    PhD, Branch Chief (Acting), Antibacterials Program
    BARDA
    Hasan Jafri at World Anti-Microbial Congress US 2016
    Hasan Jafri
    Sr. Director, Clinical R&D, Infectious Diseases and Vaccines MedImmune, AstraZeneca,Coordinator, COMBACTE
    Innovative Medicines Initiative
  • Anders Karlén at World Anti-Microbial Congress US 2016
    Anders Karlén
    Managing Entity, ENABLE, Professor in Computer-aided Drug Design
    Uppsala University
    Barbara Kerstiens at World Anti-Microbial Congress US 2016
    Barbara Kerstiens
    Deputy Head of Unit, Fighting Infectious Diseases and Advancing Public Health Research and Innovatio
    European Commission
  • Dr Jane Knisely at World Anti-Microbial Congress US 2016
    Dr Jane Knisely
    Program Officer, Bacteriology and Mycology Branch, NIAID
    NIH - NIAID
    Joe Larsen at World Anti-Microbial Congress US 2016
    Joe Larsen
    Acting Deputy Director
    BARDA
  • Frédéric Laurent at World Anti-Microbial Congress US 2016
    Frédéric Laurent
    Professor of Microbiology, National Reference Center on Staphylococcus
    University Hospital, Lyon
    David Mantus at World Anti-Microbial Congress US 2016
    David Mantus
    Chief Development Officer
    Arsanis Inc
  • Anthony McDonnell at World Anti-Microbial Congress US 2016
    Anthony McDonnell
    Head of Economic Research
    Review on Antimicrobial Resistance
    Sumathi Nambiar at World Anti-Microbial Congress US 2016
    Sumathi Nambiar
    Director, Division of Aniti-Infective Products
    FDA
  • Professor Kevin Outterson at World Anti-Microbial Congress US 2016
    Professor Kevin Outterson
    Professor of Health Law, Bioethics and Human Rights
    Boston University School of Law
    Jean Patel at World Anti-Microbial Congress US 2016
    Jean Patel
    Deputy Director, Office of Antimicrobial Resistance
    Center for Disease Control & Prevention
  • Robin Patel at World Anti-Microbial Congress US 2016
    Robin Patel
    Professor of Microbiology and Medicine
    Mayo Clinic
    Edmund Pezalla at World Anti-Microbial Congress US 2016
    Edmund Pezalla
    VP
    Aetna Pharmacy Management
  • Aleks Radovic-Moreno at World Anti-Microbial Congress US 2016
    Aleks Radovic-Moreno
    Senior Associate
    PureTech Health
    Ribhi Shawar at World Anti-Microbial Congress US 2016
    Ribhi Shawar
    Branch Chief, Division of Microbiology
    CDRH OIR FDA
  • Mr Larry Tsai at World Anti-Microbial Congress US 2016
    Mr Larry Tsai
    VP, Clinical Development
    Tetraphase Pharmaceuticals
    Mr Lucas Wiarda at World Anti-Microbial Congress US 2016
    Mr Lucas Wiarda
    Global Marketing Director & Head of Sustainable Antibiotics Program
    DSM Sinochem Pharmaceuticals
  • David Huang at World Anti-Microbial Congress US 2016
    David Huang
    Chief Medical Officer
    Motif Bio
    Dawn O'Connell at World Anti-Microbial Congress US 2016
    Dawn O'Connell
    Deputy Chief of Staff
    United States Department of Health & Human Services
  • Jennifer Auchtung at World Anti-Microbial Congress US 2016
    Jennifer Auchtung
    Asst Professor, Therapeutic Microbiology Laboratory, Dept. of Molecular Virology and Microbiology
    Baylor College of Medicine
    Byron Beeler at World Anti-Microbial Congress US 2016
    Byron Beeler
    Board Member
    Natural MA
  • Dr Debabrata Biswas at World Anti-Microbial Congress US 2016
    Dr Debabrata Biswas
    Assistant Professor
    University of Maryland University College
    Ramiz Boulos at World Anti-Microbial Congress US 2016
    Ramiz Boulos
    CEO
    Boulos & Cooper
  • Dr Nick Conley at World Anti-Microbial Congress US 2016
    Dr Nick Conley
    Chief Executive Officer
    EpiBiome
    Mr David Larwood at World Anti-Microbial Congress US 2016
    Mr David Larwood
    CEO and Founder
    Valley Fever Solutions
  • James Liang at World Anti-Microbial Congress US 2016
    James Liang
    Professor, Dept. of Biomedical Engineering, Chemistry and Biology
    Stevens Institute of Technology
    Randy D Milby at World Anti-Microbial Congress US 2016
    Randy D Milby
    Chief Executive Officer
    CorMedix Inc.
  • Mr Neil Miller at World Anti-Microbial Congress US 2016
    Mr Neil Miller
    Chief Scientific Officer
    Auspherix Ltd
    Mr Steve Parkinson at World Anti-Microbial Congress US 2016
    Mr Steve Parkinson
    President and Chief Executive Officer
    Lakewood-Amedex Inc.
  • Mr Malcolm Thomas at World Anti-Microbial Congress US 2016
    Mr Malcolm Thomas
    COO
    Agile Sciences, Inc.
    Barry Wohl at World Anti-Microbial Congress US 2016
    Barry Wohl
    CBO
    SymbalRx
  • Robert Yancey, Jr. at World Anti-Microbial Congress US 2016
    Robert Yancey, Jr.
    Infectious Diseases Consultant
    Antibiotic Adjuvant, Inc

 

 

We are currently inviting world-class speakers for the European Congress

 

APPLY TO SPEAK

WHO ATTENDS?

Past series attendees include

 

Accele Biopharma     Accelerate Diagnostics     Achaogen     Actavis     Actelion Clinical Research, Inc.     adtec europe Ltd     Aeras     Aetna Pharmacy Management     Agile Sciences, Inc.     Alliance for Aging Research     American Society for Microbiology     Amplyx Pharmaceuticals, Inc     Antibiotic Adjuvant, Inc     Antibiotics - The Perfect Storm     Arsanis Inc     Asepticys     Astellas Pharma U.S.     AstraZeneca     Auspherix Ltd     BARDA     Basilea Pharmaceutica Ltd     Baylor College of Medicine     Becton Dickinson     Biofilm Control     BioFire Defense     Bio-Manguinhos/Fiocruz     Biomerieux, Inc     Boston University School of Law     Boulos & Cooper     C.U.B.R.C. Inc     CARB-X     Catholic University of Brasilia     CDC     CDRH OIR FDA     Cempra     Cempra, Inc.     Center for Disease Control & Prevention     Center for Infectious Disease Research and Policy (CIDRAP)     Center for Scientific Review/NIH     Cepheid     Cidara Therapeutics     College of Staten Island     Community for Open Antimicrobial Drug Discovery     Contrafect Corporation     CorMedix Inc     COVANCE INC.     Crestone Inc     Curza     D.S.M. Sinochem Pharmaceuticals     Danish Broadcasting Corp     Department of Health and Human Services     Diversigen     DSM Sinochem Pharmaceuticals     Duke University     Emergent BioSolutions Inc     Entasis Therapeutics     EpiBiome     European Commission     Evotec     F. Hoffmann-La Roche Ltd     FDA     Forge Therapeutics     Fox Therapeutics     George Mason University, College of Science     George Washington University School of Medicine & Health Sciences     GSK     Harvard University     HHS/BARDA     Howard University Hospital     IMMT     Independent Consultant     InnoTune BVBA     Innovative Medicines Initiative     Institute for Life Science Entrepreneurship, Kean University     Intralytix Inc.     Istituti Fisioterapici Ospitalieri     Iterum Therapeutics     Ivogen     Janssen Pharmaceuticlas Ltd     JMI Laboratories     Lakewood-Amedex Inc.     Lund University     Massachusetts General Hospital     Massachusetts Institute of Technology     Mayo Clinic     McMaster University     MedImmune Inc     MedStar Union Memorial Hospital     Meiji Seika Pharma Co., Ltd.     Merck & Co.     Mericopia Integrated Healt System     Motif BioSciences, Inc.     MRIGlobal     Nabriva Therapeutics     National Institutes of Health     Natural MA     Nesta     NIH - NIAID     Northeastern University     Novan Therpeutics     Ohio Northern University     OpGen Inc     PAHO/WHO     Paratek     Pennsylvania State University     Pew Charitable Trusts     Pfizer     Phagelux     Physician Resources     Politico     Polypharmakos Limited     PSI     PSI CRO     Public Health Agency of Canada     Public Health England     PureTech Health     Raleigh Fitkin Memorial Hospital     Reagan Udall Foundation for the F.D.A.     Review on Antimicrobial Resistance     Rho     Roche Innovation Center New York     S.R. One     Sample6     Sandoz     Sanofi     Science Speaks Blog     Scynexis, Inc.     Self     Shionogi Inc     Spero Therapeutics     State University of New York at Buffalo     Stevens Institute of Technology     SymbalRx     Telephus Medical Llc     Tetraphase Pharmaceuticals     Teva     The Conafay Group     The Medicines Company     The Pew Charitable Trusts     Tiber Creek Partners     Touro University Nevada     U.S. Department of Health & Human Services     UCLA David Geffen School of Medicine     UMSL     United States Department of Health & Human Services     UnityPoint Health-Meriter Hospital     University Hospital, Lyon     University of California Merced     University of California San Francisco     University of Cambridge     University of Maryland University College     University of Missouri-St. Louis     University of Rochester Medical Center     University of Utah School of Medicine     University of Warwick     ppsala University     Vanderbilt University     VenatoRx Pharmaceuticals Inc     Viamet Pharmaceuticals     Vivexia     Wellcome Trust     Zeus capital

 

DOWNLOAD PROSPECTUS

TESTIMONIALS

Testimonials from our event in Washington, DC, held each September for the past two years

 

Biofilm Control Logo

"The exceptional quality of the attendees: top management of Pharm Industy, excellent contacts FDA, NIH."

CEO, Biofilm Control

Spero Therapeutics Logo

"Very good conference for networking purposes."

Head of Biology, Spero Therapeutics

 

Evotec Logo

"Good format and range of delegates. Plenty of time to network."

Senior Vice President of Anti Infective Operations, Evotec

Agile Sciences Logo

"Interesting content and very focused subject area."

COO, Agile Sciences, Inc.

 

EpiBiome Logo

"Organizers did a wonderful job, and I learned a tremendous amount about the state of the field!"

Chief Executive Officer, EpiBiome

Cepheid logo

"The content was fantastic."

Solutions Manager, Cepheid

 

DOWNLOAD PROSPECTUS

World Anti-Microbial Resistance Congress Europe

A UNIQUE OPPORTUNITY

 

Established brands use our events to consolidate their position, grow market share, or enter new sectors or territories. Challenger brands use our events to demonstrate thought leadership, establish their point of difference, and win over new customers. Join us!

 

DOWNLOAD PROSPECTUS

Contact us

To sponsor or exhibit contact:
Alistair Wilmot
+44 (0)207 092 1174

alistair.wilmot@terrapinn.com


To speak:
Chris Shanks
+44 (0)207 092 1151

chris.shanks@terrapinn.com